> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# Tandem Gets FDA Clearance For Tubeless Mobi — Users Can Keep Their Existing Pumps
- URL: https://www.bullished.co/tandem-gets-fda-clearance-for-tubeless-mobi-users-can-keep-their-existing-pumps-fd77c650/
- Published: 2026-11-13T13:51:11.000Z
- Updated: 2026-11-13T13:51:11.000Z
- Description: The infusion set allows up to seven days of wear, while cartridges have a three-day limit and new supplies will be pharmacy-only.
- Author: Matteo Parrino
- Tags: SEC Filings, TNDM, Industry: Healthcare

[Tandem Diabetes Care](https://www.bullished.co/tag/tndm/), which designs and sells insulin pumps and related software, received FDA clearance Thursday to turn existing Mobi pumps into [tubeless devices](https://www.businesswire.com/news/home/20261112487071/en/Tandem-Mobi-Now-FDA-Cleared-as-Worlds-First-and-Only-Tubeless-AID-System-with-up-to-Seven-Days-of-Wear?ref=bullished.co). The company said in an SEC filing Friday that customers can use a new cartridge and infusion set while keeping their current pump and its automated insulin-adjustment technology.

## Seven-Day Wear, Three-Day Cartridges

The FDA cleared the tubeless infusion set for up to seven days of wear. The insulin cartridge has a separate limit of three days of use.

Mobi owners will be able to choose tubed or tubeless delivery without replacing the pump. Both configurations use Control-IQ+, Tandem's technology for automatically adjusting insulin dosing.

President and CEO John Sheridan said the ability to offer different ways to wear Mobi was part of its original design.

## Pharmacies Get The New Supplies

Tandem's launch announcement said the tubeless supplies will be [available exclusively](https://www.businesswire.com/news/home/20261112487071/en/Tandem-Mobi-Now-FDA-Cleared-as-Worlds-First-and-Only-Tubeless-AID-System-with-up-to-Seven-Days-of-Wear?ref=bullished.co) through pharmacies for customers with pharmacy benefits. The company estimates that its pharmacy coverage reaches approximately 50% of insured U.S. lives.

The new configuration adds to a business that sells pumps alongside recurring-use supplies, including insulin cartridges and infusion sets. Tandem's Mobi and t:slim X2 pumps work with continuous glucose monitoring sensors and Control-IQ+ to automate dosing.

According to its 2025 annual report, Tandem serves nearly 500,000 people across more than 25 countries. Its pumps are assembled in San Diego, California.

## Canada Expands t:slim X2 Use

Tandem also announced [expanded Canadian authorization](https://markets.ft.com/data/announce/detail?dockey=600-202611120830BIZWIRE%5FUSPRX%5F%5F%5F%5F20261112%5FBW868686-1&ref=bullished.co) Thursday for t:slim X2\. The changes add compatibility with Abbott's FreeStyle Libre 3 Plus sensor and permit use during pregnancies involving type 1 diabetes and by adults with type 2 diabetes.

The pregnancy authorization drew on trial findings published in October 2025\. A randomized study of more than [300 people](https://markets.ft.com/data/announce/detail?dockey=600-202611120830BIZWIRE%5FUSPRX%5F%5F%5F%5F20261112%5FBW868686-1&ref=bullished.co) supported the adult type 2 authorization, with results published in March 2025.

Tandem plans a full U.S. launch of the tubeless cartridge and infusion set in the first half of 2027.

Learn

- [Item 8.01: other events →](https://www.bullished.co/learn/8-k-items-explained/#item-801-other-events)  
From 8-K Items Explained: What Every Item Code From 1.01 To 9.01 Tells You, With Examples

### Sources

- [8-K Filing — TANDEM DIABETES CARE INC (TNDM)](https://www.sec.gov/Archives/edgar/data/0001438133/000143813326000148/tndm-20261112.htm?ref=bullished.co) — SEC EDGAR
- [Tandem Diabetes Care Receives Multiple Health Canada Approvals for t:slim X2 Insulin Pump – Company Announcement - FT.com](https://markets.ft.com/data/announce/detail?dockey=600-202611120830BIZWIRE%5FUSPRX%5F%5F%5F%5F20261112%5FBW868686-1&ref=bullished.co) — Financial Times
- [Tandem Mobi Now FDA Cleared as World’s First and Only Tubeless AID System with up to Seven Days of Wear](https://www.businesswire.com/news/home/20261112487071/en/Tandem-Mobi-Now-FDA-Cleared-as-Worlds-First-and-Only-Tubeless-AID-System-with-up-to-Seven-Days-of-Wear?ref=bullished.co) — businesswire.com

### More on Tandem Diabetes Care

- [Goldman Sachs Reports A 5.9% Passive Stake In Tandem Diabetes Care](https://www.bullished.co/goldman-sachs-reports-a-5-9-passive-stake-in-tandem-diabetes-care-8ee29edd/)
- [Tandem Diabetes Care Nears Operating Break-Even — But U.S. Pump Sales Fall 2%](https://www.bullished.co/tandem-diabetes-care-nears-operating-break-even-but-u-s-pump-sales-fall-2-5104e5a2/)
- [Tandem Diabetes CFO Tells Analysts To 'Recalibrate' 2027 Models As Pharmacy Rollout Lags](https://www.bullished.co/tandem-diabetes-cfo-tells-analysts-to-recalibrate-2027-models-as-pharmacy-rollout-lags-1d39b22f/)

[All Tandem Diabetes Care (TNDM) coverage →](https://www.bullished.co/tag/tndm/)